Therapeutic potential of chloroquine added to zidovudine plus didanosine for HIV-1 infected children.
Artículo
en Inglés
| IMSEAR
| ID: sea-39548
ABSTRACT
OBJECTIVE:
To evaluate the efficacy and safety of CHQ in a combination treatment with ZDV/ddI in HIV-1-infected children. MATERIAL ANDMETHOD:
Fifty five HIV-infected children were randomly enrolled into 3 treatment groups (I) ZDV + ddI (n = 25); and (II) ZDV + ddI + CHQ (n = 21); and (III) ZDV + ddI experienced children were non-randomly added CHQ (n = 9). Weight, CD4+ T-lymphocytes and plasma HIV-RNA were measured at weeks 0, 8 and 24.RESULTS:
Fifteen, 16 and 8 children from Groups I, II and III were evaluated. No significant improvement in the mean Z-score for weight in groups I and II, but a decrease occurred in group III after 6 months of therapy. In group I, II and III, the respective change in the mean CD4+ T-lymphocyte percentage was +6.7, +4.0 and -0.6. The decrease in the plasma HIV-RNA log was 0.9, 1.1 and 0.7, respectively. There was a trend for more nausea/vomiting in group II/III and more opportunistic infections in group III.CONCLUSION:
1. The addition of chloroquine in ZDV/ddI regimen provided no significant improvement in clinical, immunological and virological parameters. 2. Chloroquine induced immunosuppression and nausea complicated its use.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Femenino
/
Humanos
/
Masculino
/
Zidovudina
/
Infecciones por VIH
/
Niño
/
Preescolar
/
Cloroquina
/
VIH-1
/
Didanosina
Tipo de estudio:
Ensayo Clínico Controlado
Idioma:
Inglés
Año:
2006
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS